MindMaze Therapeutics Taps Neuroscience Pioneer Krakauer as U.S. Growth Advisor

  • MindMaze Therapeutics appointed Prof. John W. Krakauer as strategic advisor to support U.S. expansion on August 12, 2026.
  • Krakauer is the original scientific creator of MindPod® and a leading expert in motor neuroscience and neurorehabilitation.
  • The move follows a two-year RWE program showing 60% increase in therapy delivery and 17% higher community discharge rates.
  • MindMaze recently established U.S. headquarters in Charlotte's Innovation District and partnered with Vibra Healthcare.

MindMaze's appointment of Krakauer underscores its push to operationalize neuroplasticity-driven recovery solutions. The move comes as healthcare systems increasingly seek scalable platforms to address clinician shortages in neurological rehabilitation. With a growing body of real-world evidence and strategic U.S. partnerships, MindMaze is positioning itself at the forefront of neurorestorative medicine commercialization.

Clinical Validation
How MindMaze will leverage Krakauer's research to strengthen its high-dose, high-intensity paradigm in real-world settings.
Market Penetration
Whether the U.S. expansion can capitalize on Vibra Healthcare partnership and Charlotte headquarters to scale patient access.
Regulatory Dynamics
The pace at which MindMaze advances FDA and CE-marked products through the care continuum, including home-based therapy.